Immuron marks surge in Travelan® sales on eve of entry into US via

Immuron Ltd (NASDAQ:IMRN, ASX:IMC), a biopharmaceutical company headquartered in Australia, says sales of its immune supplement Travelan® have soared.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.